(Image via CrunchBase) Global pharmaceutical giant Pfizer Inc. is transforming its use of analytics from a theoretical exercise into a real-time execution engine powered in part by tablet PCs and click-stream data  but primarily by the urgency of shifting business models for Lipitor and other products. In a compelling Q&A interview with MIT Sloan Management Review, Pfizer VP of U.S. Commerc…